Xywav oral solution
Ended Awarded Last action
- Contract number
- 36C26024F0282
- Awardee
-
Jazz Pharmaceuticals, Inc. UEI H9AXCNRA5NE6
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $147,146
Award facts
- Contract value 100% obligated
- $147,145.65 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Normandy, MO 63121, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$92,067 | |
| Funding Only Action | -$6,299 | |
| Original award | $245,511 |
About this award
Jazz Pharmaceuticals, Inc. was awarded a $147,145.65 firm fixed-price delivery order by the Department of Veterans Affairs' Veterans Integrated Service Network 20 on March 8, 2024, with an ultimate completion date of March 8, 2025. The delivery order, issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), is for Xywav oral solution and associated invoice reconciliation services. Performance will be executed in Normandy, Missouri. This award was issued without a set-aside designation, indicating unrestricted competitive procurement. Jazz Pharmaceuticals, a global biopharmaceutical company headquartered in Palo Alto, California, serves as the prime contractor with no identified subcontractors.
This delivery order is issued against Jazz Pharmaceuticals' single-award Blanket Purchase Agreement with the VA's National Acquisition Center, valued at $161.2 million and expiring August 15, 2026. Xywav is a specialty pharmaceutical product indicated for treating narcolepsy and sleep disorders affecting veteran populations. The BPA, which became effective August 16, 2024, authorizes procurement of sleep disorder medications across multiple Veterans Integrated Service Networks and represents the VA's strategic reliance on Jazz Pharmaceuticals as a primary supplier of these critical medications to support veteran healthcare services.
Quick answers
Who was awarded contract 36C26024F0282?
36C26024F0282 was awarded to Jazz Pharmaceuticals, Inc. by Veterans Integrated Service Network 20 (Veterans Health Administration) on March 8, 2024.
How much is contract 36C26024F0282 worth?
The government has obligated $147,146 on 36C26024F0282.
Is contract 36C26024F0282 an order under another contract?
Yes. 36C26024F0282 is a delivery order under 36F79719D0205, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26024F0282 competed?
The extent of competition for 36C26024F0282 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award